InMed Pharmaceuticals (INM) Return on Sales (2021 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Return on Sales of 0.02% for Q4 2025, little changed year-over-year from 0.02% in Q4 2024, and down 60.4% quarter-over-quarter from 0.02% in Q3 2025.
InMed Pharmaceuticals (INM) Return on Sales (2021 - 2025) Analysis & Trends
InMed Pharmaceuticals' Return on Sales history runs 5 years deep, the most recent figure standing at 0.02% for Q4 2025.
- In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
- Return on Sales for Q4 2025 stood at 0.02%, down from 0.02% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q1 2025, with the low at 0.16% in Q4 2021.
- The 5-year median for Return on Sales is 0.02% (2023), against an average of 0.04%.
- The sharpest annual moves came in 2023 and 2024: Return on Sales rose 15 bps in 2023, then decreased 1 bps in 2024.
- InMed Pharmaceuticals' Return on Sales stood at 0.16% in 2021, then jumped by 72 bps to 0.04% in 2022, then surged by 73 bps to 0.01% in 2023, then slumped by 94 bps to 0.02% in 2024, then decreased by 7 bps to 0.02% in 2025.
- Business Quant data shows INM's Return on Sales at 0.02% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.11% |
| Jun 30, 2022 | -0.15% |
| Mar 31, 2022 | -0.06% |
| Dec 31, 2021 | -0.16% |